This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Effect of IDEA-070 on Pain and Inflammation Induced by PDT

This study has been completed.
Information provided by:
IDEA AG Identifier:
First received: December 22, 2005
Last updated: March 19, 2009
Last verified: March 2009
Primary objectives: effect of IDEA-070 compared to placebo on pain and inflammation induced by PDT. The primary objective is to detect a statistically significant difference of pain and inflammation induced by PDT in test areas treated with IDEA-070 compared to placebo-treated areas.

Condition Intervention Phase
Actinic Keratosis Drug: IDEA-070 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Safety and Efficacy of IDEA-070 for the Treatment of Pain and Inflammation Induced by Photodynamic Therapy of Actinic Keratosis

Resource links provided by NLM:

Further study details as provided by IDEA AG:

Estimated Enrollment: 24
Study Start Date: January 2006
Estimated Study Completion Date: July 2006

Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Diagnosis ot actinic keratosis to be treated with PDT affecting equal sized areas of both sides of the head affecting at least 10% of the area of photoexposure

Exclusion Criteria:

Morpheaform basal cell carcinoma, Major hypertrophy of lesions, Porphyria, Topical treatment with 5-FU, cryotherapy, PDT, diclophenac sodium, and other less common treatments on the treatment area or systemic treatment within 3 month prior to screening, Concomitant use of other analgesics including topical NSAIDs

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00269074

Dermatological department of university hospital
Duesseldorf, Nordrhein-Westfalen, Germany, D-40225
Sponsors and Collaborators
Principal Investigator: Julia Reifenberger, PD Dr. med. Dermatological department of university Duesseldorf
  More Information Identifier: NCT00269074     History of Changes
Other Study ID Numbers: CL-070-II-02
EudrCT number: 2005-002875-34
Study First Received: December 22, 2005
Last Updated: March 19, 2009

Additional relevant MeSH terms:
Keratosis, Actinic
Pathologic Processes
Skin Diseases
Precancerous Conditions
Neoplasms processed this record on September 21, 2017